AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Miglino, M Grasso, R Pietrasanta, D Palmisano, GL Berisso, G Clavio, M Pierri, I Santini, G Canepa, L Gobbi, M
Citation: M. Miglino et al., Detection of minimal residual disease in B-lymphoproliferative disorders: A three step SSCP-PCR method, J EXP CL C, 20(1), 2001, pp. 95-101

Authors: di Grazia, C Raiola, AM Van Lint, MT Lamparelli, T Gualandi, F Berisso, G Bregante, S Dominietto, A Mordini, N Bruno, B Frassoni, F Bacigalupo, A
Citation: C. Di Grazia et al., Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft, HAEMATOLOG, 86(6), 2001, pp. 646-651

Authors: Dominietto, A Raiola, AM van Lint, MT Lamparelli, T Gualandi, F Berisso, G Bregante, S Frassoni, F Casarino, L Verdiani, S Bacigalupo, A
Citation: A. Dominietto et al., Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose, BR J HAEM, 112(1), 2001, pp. 219-227

Authors: Raiola, AM Van Lint, MT Lamparelli, T Gualandi, F Benvenuto, F Figari, O Mordini, N Berisso, G Bregante, S Frassoni, F Bacigalupo, A
Citation: Am. Raiola et al., Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria, HAEMATOLOG, 85(1), 2000, pp. 59-62

Authors: Lamparelli, T van Lint, MT Gualandi, F Raiola, AM Barbanti, M Sacchi, N Ficai, G Ghinatti, C Bregante, S Berisso, G Dominietto, A Di Grazia, C Bruno, B Sessarego, M Casarino, L Verdiani, S Bacigalupo, A
Citation: T. Lamparelli et al., Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin, BONE MAR TR, 26(12), 2000, pp. 1305-1311

Authors: Bregante, S Bertilson, S Tedone, E Van Lint, MT Trespi, G Mordini, N Berisso, G Gualandi, F Lamparelli, T Figari, O Benvenuto, F Raiola, AM Bacigalupo, A
Citation: S. Bregante et al., Foscarnet prophylaxis of cytomegalovirus infections in patients undergoingallogeneic bone marrow transplantation (BMT): a dose-finding study, BONE MAR TR, 26(1), 2000, pp. 23-29

Authors: Chiodi, S Spinelli, S Ravera, G Petti, AR van Lint, MT Lamparelli, T Gualandi, F Occhini, D Mordini, N Berisso, G Bregante, S Frassoni, F Bacigalupo, A
Citation: S. Chiodi et al., Quality of life in 244 recipients of allogeneic bone marrow transplantation, BR J HAEM, 110(3), 2000, pp. 614-619

Authors: Raiola, AM Van Lint, MT Lamparelli, T Gualandi, F Mordini, N Berisso, G Bregante, S Frassoni, F Sessarego, M Fugazza, G Di Stefano, F Pitto, A Bacigalupo, A
Citation: Am. Raiola et al., Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age, BR J HAEM, 109(4), 2000, pp. 716-721

Authors: Bacigalupo, A Vitale, V Corvo, R Barra, S Lamparelli, T Gualandi, F Mordini, N Berisso, G Bregante, S Raiola, AM Van Lint, MT Frassoni, F
Citation: A. Bacigalupo et al., The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation, BR J HAEM, 108(1), 2000, pp. 99-104

Authors: Galotto, M Berisso, G Delfino, L Podesta, M Ottaggio, L Dallorso, S Dufour, C Ferrara, GB Abbondandolo, A Dini, G Bacigalupo, A Cancedda, R Quarto, R
Citation: M. Galotto et al., Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients, EXP HEMATOL, 27(9), 1999, pp. 1460-1466

Authors: Bacigalupo, A Oneto, R Bruno, B Soracco, M Lamparelli, T Gualandi, F Occhini, D Raiola, AM Mordini, N Berisso, G Bregante, S Dini, G Lombardi, A Van Lint, MT Brand, R
Citation: A. Bacigalupo et al., Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubin, BONE MAR TR, 24(6), 1999, pp. 653-659
Risultati: 1-11 |